Bladder Treatment Study with NT 201 and Vibe System
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a new bladder treatment called NT 201 combined with a device called the Vibe System for women with overactive bladder (frequent, urgent need to urinate). The treatment is injected directly into the bladder and may help reduce urgency and leaking.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and between 18 and 80 years old
- You have been diagnosed with overactive bladder for at least 6 months
- You experience at least 8 times of urination per day and at least 5 leaking episodes per day (on average over 3 days)
- If you take overactive bladder medications, you've been on a stable dose for at least 1 month
- You don't have a history of neurological conditions like Parkinson's, MS, or stroke that affect the bladder
- Your post-void residue (leftover urine after urination) is 150 ml or less
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized nerve stimulation system for women with overactive bladder that hasn't improved with other treatments. It aims to see if the device is safe and works well.
This study tests a non-invasive device that stimulates a nerve in your leg to help reduce overactive bladder symptoms, like frequent urination and sudden leaks. It aims to see if this treatment can safely improve bladder control.
This trial tests a non-surgical device that uses mild electrical stimulation to treat overactive bladder. It may help if you have a sudden, strong need to pee often or wake up at night to pee.
This trial tests a new procedure that uses radiofrequency energy to calm the nerve responsible for overactive bladder in women. It aims to reduce urge-related urine leaks without surgery or medications.
This study tests a new version of a sacral nerve stimulation device (Axonics model 5101) for people with overactive bladder. It aims to see if the device is safe and works well to reduce sudden urges and frequent urination.
This study tests a new treatment, TRG-200 KIT, given directly into the bladder for people with overactive bladder (OAB) that hasn't improved with other medications. It may help reduce urgency, frequent urination, and nighttime bathroom trips.
Hear when a new Overactive Bladder (OAB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.